Arena Pharmaceuticals Stock Working Capital
Arena Pharmaceuticals fundamentals help investors to digest information that contributes to Arena Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Arena Stock. The fundamental analysis module provides a way to measure Arena Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Arena Pharmaceuticals stock.
Arena |
Arena Pharmaceuticals Company Working Capital Analysis
Arena Pharmaceuticals' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Arena Pharmaceuticals Working Capital | 124.94 M |
Most of Arena Pharmaceuticals' fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Arena Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionIn accordance with the company's disclosures, Arena Pharmaceuticals has a Working Capital of 124.94 M. This is 70.65% lower than that of the Healthcare sector and 76.8% lower than that of the Biotechnology industry. The working capital for all United States stocks is 91.55% higher than that of the company.
Arena Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Arena Pharmaceuticals' direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Arena Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Arena Pharmaceuticals by comparing valuation metrics of similar companies.Arena Pharmaceuticals is currently under evaluation in working capital category among related companies.
Arena Fundamentals
| Return On Equity | -70.3 | |||
| Return On Asset | -34.53 | |||
| Current Valuation | 5.36 B | |||
| Shares Outstanding | 61.56 M | |||
| Shares Owned By Insiders | 0.55 % | |||
| Shares Owned By Institutions | 84.05 % | |||
| Number Of Shares Shorted | 5.11 M | |||
| Price To Earning | 4.53 X | |||
| Price To Book | 7.65 X | |||
| Revenue | 54 K | |||
| Gross Profit | (419.45 M) | |||
| EBITDA | (541.79 M) | |||
| Net Income | (616.43 M) | |||
| Cash And Equivalents | 550.47 M | |||
| Cash Per Share | 8.93 X | |||
| Total Debt | 51.31 M | |||
| Debt To Equity | 0.08 % | |||
| Current Ratio | 8.59 X | |||
| Book Value Per Share | 13.07 X | |||
| Cash Flow From Operations | (452.02 M) | |||
| Short Ratio | 3.83 X | |||
| Earnings Per Share | (9.72) X | |||
| Price To Earnings To Growth | 0.46 X | |||
| Number Of Employees | 448 | |||
| Beta | 0.55 | |||
| Market Capitalization | 6.16 B | |||
| Total Asset | 256.79 M | |||
| Retained Earnings | (1.19 B) | |||
| Working Capital | 124.94 M | |||
| Current Asset | 174.84 M | |||
| Current Liabilities | 49.9 M | |||
| Z Score | 59.8 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Arena Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Arena Pharmaceuticals' short interest history, or implied volatility extrapolated from Arena Pharmaceuticals options trading.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Arena Stock
If you are still planning to invest in Arena Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Arena Pharmaceuticals' history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |